Inactive Instrument
Lotus Pharmaceuticals, Inc. Stock Other OTC
Stocks
LTUS
US5457152032
Pharmaceuticals
OTC Markets Traded| Market Cap | 9.74M 8.38M 7.88M 7.2M 13.47M 920M 13.52M 93.12M 36.1M 471M 36.56M 35.76M 1.52B | P/E 2009 |
3.88x | P/E 2010 | 4.84x |
|---|---|---|---|---|---|
| Enterprise Value | 14.38M 12.39M 11.64M 10.64M 19.9M 1.36B 19.97M 138M 53.33M 696M 54M 52.83M 2.25B | EV / Sales 2009 |
1.02x | EV / Sales 2010 | 0.95x |
| Free-Float |
99% | Yield 2009 * |
-
| Yield 2010 | - |
| 1 day | +41.51% |
| Manager | Title | Age | Since |
|---|---|---|---|
Georgene Rivers
CEO | Chief Executive Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Georgene Rivers
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +41.51% | -18.92% | - | - | 7.93M | |
| -0.89% | -1.09% | +20.02% | +71.25% | 48.26B | |
| -1.72% | -1.15% | +47.28% | +115.51% | 40.5B | |
| -2.01% | -5.96% | +10.68% | +80.50% | 11.83B | |
| -0.70% | -2.70% | -12.22% | +11.80% | 11.85B | |
| +0.57% | -0.56% | +26.56% | +154.33% | 9.36B | |
| -1.67% | -0.35% | +41.04% | -12.04% | 7.37B | |
| +0.08% | -4.11% | +22.91% | +43.56% | 7.5B | |
| -0.89% | -3.09% | +22.42% | +220.05% | 7.28B | |
| -0.16% | -2.36% | -42.27% | +15.39% | 5.19B | |
| Average | +3.41% | -2.12% | +15.16% | +77.82% | 16.57B | |
| Weighted average by Cap. | -1.06% | -1.72% | +23.66% | +84.31% |
| 2009 | 2010 | |
|---|---|---|
| Net sales | 57.82M 49.8M 46.78M 42.77M 80.01M 5.46B 80.29M 553M 214M 2.8B 217M 212M 9.03B | 72.7M 62.61M 58.81M 53.77M 101M 6.87B 101M 695M 270M 3.52B 273M 267M 11.36B |
| Net income | 16.43M 14.15M 13.29M 12.15M 22.74M 1.55B 22.82M 157M 60.93M 796M 61.7M 60.35M 2.57B | 14.42M 12.42M 11.67M 10.67M 19.96M 1.36B 20.03M 138M 53.49M 699M 54.16M 52.98M 2.25B |
| Net Debt | 5.29 4.56 4.28 3.92 7.33 500.22 7.35 50.63 19.63 256.35 19.88 19.44 827.01 | 4.65 4 3.76 3.44 6.43 439.07 6.45 44.44 17.23 225.02 17.45 17.07 725.92 |
Employees
-
Sector
Pharmaceuticals
